SCHEMBL1334965

SCHEMBL1334965

COc1ccccc1[C@H]1CO[C@@H](C)CN1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
HTR2A P28223 1/20 0.40
HTR2B P41595 1/20 0.40
CYP19A1 P11511 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
TACR1 P25103 2/20 0.38
DRD2 P14416 1/20 0.38
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ADRA2C P18825 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1334966 1.00 HTR2C (0.43) HTR2CMEN1KMT2AUSP2HTR2A
SCHEMBL1333921 0.78 SLC6A3 (0.38) HTR2CKMT2AHTR2AHTR2BMAPT
SCHEMBL27742413 0.78 HTR2B (0.35) HTR2CMEN1KMT2AHTR2AHTR2B
SCHEMBL1335194 0.78 MEN1 (0.38) HTR2CMEN1KMT2AHTR2BCYP19A1
SCHEMBL2596476 0.78 SLC6A3 (0.38) HTR2CKMT2AHTR2AHTR2BMAPT
SCHEMBL1333923 0.78 SLC6A3 (0.38) HTR2CKMT2AHTR2AHTR2BMAPT
SCHEMBL1335109 0.78 MEN1 (0.38) HTR2CMEN1KMT2AHTR2BCYP19A1
SCHEMBL25478453 0.76 PRCP (0.31) HTR2B
SCHEMBL24367125 0.75 HTR2C (0.49) HTR2CMEN1KMT2AUSP2HTR2A
SCHEMBL1334836 0.74 SLC6A2 (0.47) MEN1KMT2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281854-A1 MORPHOLINE COMPOUNDS PFIZER INC 2011-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281854-A1 MORPHOLINE COMPOUNDS REN, MC2R, NR3C2 HTR2C 367/4885MEN1 62/4885KMT2A 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.